Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2016 December;58(4) > Panminerva Medica 2016 December;58(4): 349-50

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti
Per citare questo articolo

PANMINERVA MEDICA

Rivista di Medicina Interna


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,698


eTOC

 

LETTERS TO THE EDITOR  


Panminerva Medica 2016 December;58(4): 349-50

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

Extension of the stability of anticancer drugs in pharmaceutical practice

Francesca BARATTA 1, Franca GOFFREDO 2, Laura ANNARATONE 3, Anna SAPINO 3, Oscar BERTETTO 4, Paola BRUSA 1

1 Department of Science and Pharmaceutical Technology, University of Turin, Turin, Italy; 2 Oncology Foundation of Piedmont Region, Institute for Cancer Research and Treatment (IRCC), Candiolo, Turin, Italy; 3 Department of Medical Sciences, University of Turin, Turin, Italy; 4 Interaziendale Interregionale Rete Oncologica Piemonte e Valle d’Aosta Department, A.O.U. Città della Salute e della Scienza, Turin, Italy


PDF  


inizio pagina

Publication History

Per citare questo articolo

Baratta F, Goffredo F, Annaratone L, Sapino A, Bertetto O, Brusa P. Extension of the stability of anticancer drugs in pharmaceutical practice. Panminerva Med 2016 December;58(4): 349-50. 

Corresponding author e-mail

francesca.baratta@unito.it